»» Searching for " gemcitabine "
 Related Search Tags:  Gemcitabine Gemzar Hospira HSP NYSE:HSP
Showing Results 1-1 of 1 |  Sort by:     
Page 1 of 1  |  Go to page   
Thank you for joining us. I am your host Sara Bryant at CRWE Newswire Stocks to watch. Hospira, Incorporated - symbol HSP - reported U.S. Food and Drug Administration approval of gemcitabine injection, a solution form of the drug. The solution presentations include 200 mg, 1 gm and 2 gm with a concentration of 38 milligram per milliliter. Hospira is the first company to offer gemcitabine in a solution formulation for the U.S. market. The solution formulation is designed to improve pharmacist convenience and handling safety. The oncology medication had U.S. sales of more than $750 million in 2010, led by Eli Lilly’s Gemzar. Hospira expects to launch the product in early September. Hospira is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness. Thank you for tuning in, have a great day. For CRWE Newswire, Stocks to watch, I’m Sara Bryant.
Hospira (HSP) US FDA...
Categories: Videos 
Added: 290 days ago
By: karmastock
Runtime: 1m5s
Views: 77
 | Comments: 0
Not yet rated
Page 1 of 1  |  Go to page   
About Us   |   Terms of Use   |   Privacy Policy   |   Copyright Notes   |   Contact Us   |   Help   |      |   Back to the top of this page
Copyright © 2006-2007 bongoTYube. All rights reserved.    | Page created in 0.1133 seconds.